Work With Us
Contact Us
Work With Us
Contact Us
Search
Home
About Us
Our Mission and Vision
Meet the Team
Board of Directors
Scientific Advisory Board
Our Science
About Macrocycles
Introducing MXMO
TM
Our Pipeline
Clinical Trials
Publications
What’s New
Investors
Press Releases
Events
Home
About Us
Our Mission and Vision
Meet the Team
Board of Directors
Scientific Advisory Board
Our Science
About Macrocycles
Introducing MXMO
TM
Our Pipeline
Clinical Trials
Publications
What’s New
Investors
Press Releases
Events
May 27, 2025
CID-078, an orally bioavailable cyclin A/B-RxL inhibitor elicits anti-tumor activity in neuroblastoma models
Click on the image to download
